Table 3.
Repeated measures ANOVA of physiological and ventilator parameters.
| Group | Date | Sp02 (%) | HR (bpm) | MABP (mm Hg) | FIO2 (%) | MAP (cm H2O) |
|---|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | ||
| M + F | Pre-treatment | 92.16 ± 2.59 | 147.01 ± 16.86 | 43.30 ± 7.63 | 53.82 ± 21.39 | 11.54 ± 2.94 |
| 1 h post-treatment | 93.69 ± 1.25 | 146.68 ± 14.63 | 42.90 ± 6.16 | 44.25 ± 18.47 | 10.95 ± 2.32 | |
| 3 h | 93.54 ± 4.17 | 143.98 ± 15.55 | 43.89 ± 6.05 | 42.24 ± 17.63 | 10.67 ± 2.30 | |
| 12 h | 93.64 ± 1.77 | 145.85 ± 16.21 | 43.21 ± 5.52 | 38.71 ± 16.13 | 8.20 ± 1.98 | |
| 24 h | 93.80 ± 1.47 | 143.75 ± 16.86 | 44.67 ± 7.72 | 35.74 ± 15.96 | 8.06 ± 1.95 | |
| 48 h | 94.69 ± 1.25 | 144.30 ± 16.95 | 45.91 ± 7.30 | 33.54 ± 15.01 | 7.91 ± 1.87 | |
| M | Pre-treatment | 91.56 ± 3.82 | 144.94 ± 13.45 | 44.81 ± 6.07 | 49.29 ± 18.39 | 10.74 ± 3.07 |
| 1 h post-treatment | 93.38 ± 1.93 | 142.76 ± 12.71 | 44.36 ± 5.24 | 49.29 ± 18.38 | 10.58 ± 2.87 | |
| 3 h | 93.55 ± 1.80 | 143.54 ± 13.44 | 44.55 ± 5.36 | 48.57 ± 19.04 | 10.33 ± 2.91 | |
| 12 h | 93.56 ± 2.07 | 143.57 ± 13.16 | 44.68 ± 4.91 | 47.16 ± 19.23 | 10.13 ± 2.87 | |
| 24 h | 93.95 ± 1.96 | 142.34 ± 13.58 | 45.23 ± 7.72 | 43.96 ± 19.56 | 9.87 ± 2.81 | |
| 48 h | 93.95 ± 1.95 | 140.39 ± 14.00 | 46.98 ± 5.48 | 42.58 ± 19.18 | 9.65 ± 2.65 | |
| Overall coefficient of analysis | 0.593 | 0.771 | 0.872 | 0.351 | 0.476 | |
| F and P values between groups | 1.907, 0.169 | 2.168, 0.142 | 3.120, 0.079 | 5.374, 0.021 | 3.943, 0.048 | |
| F and P values of time | 33.931, <0.001 | 3.380, <0.010 | 11.480 <0.001 | 86.207, <0.001 | 226.296, <0.001 | |
| F and P values for interaction | 1.496, 0.215 | 0.935, 0.441 | 0.500, 0.752 | 23.319, <0.001 | 88.116, <0.001 |
SpO2, oxygen saturation; HR, heart rate; bpm, beats per minute: MABP, mean arterial blood pressure; FIO2, fraction of inspired oxygen; MAP, mean airway pressure.